Human gp130 Antibody Summary
Leu24-Glu619 (Glu619Asp)
Accession # P40189
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Cell Proliferation Induced by Oncostatin M/OSM and Neutralization by Human gp130 Antibody. Recombinant Human Oncostatin M/OSM (Catalog # 295-OM) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human Oncostatin M/OSM (0.8 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human gp130 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-228-NA). The ND50 is typically 2-10 µg/mL.
Detection of Human gp130 by Western Blot. Western blot shows lysates of HeLa human cervical epithelial carcinoma cell line. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human gp130 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-228-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for gp130 at approximately 150kDa kDa (as indicated). This experiment was conducted under reducing conditions and using Western Blot Buffer Group 1.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: gp130
Gp130, the common signal transducing receptor component shared by the functional receptor complexes of the IL-6 family of cytokines, belongs to the class I cytokine receptor family. Binding of IL-6 (IL-11) to either the membrane-anchored or soluble IL-6 R (IL-11 R) initiates the association of IL-6 R (IL-11 R) with gp130 which then undergoes homo-dimerization and signal transduction. With other IL-6 family cytokines, such as LIF and OSM, signal transduction is triggered by the hetero-dimerization of gp130 and LIF R or OSM R.
Gp130 is expressed in all organs examined. Soluble gp130, which apparently arises either from proteolytic cleavage of the membrane-bound receptor or from alternative splicing, has been detected in human serum. At the present time, the in vivo functions of soluble gp130 are not clearly understood. In in vitro experiments, natural or recombinant soluble gp130 has been shown to have inhibitory effects on OSM and CNTF activities.
- Narazaki, M. et al. (1993) Blood 82:1120.
- Taga, T. and T. Kishimoto (1997) Annu. Rev. Immunol. 15:797.
Product Datasheets
Citations for Human gp130 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
11
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration
Authors: Chandrasekar, B;Mummidi, S;DeMarco, VG;Higashi, Y;
Mediators of inflammation
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
The Alzheimer's disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Authors: SA Müller, MD Shmueli, X Feng, J Tüshaus, N Schumacher, R Clark, BE Smith, A Chi, S Rose-John, ME Kennedy, SF Lichtentha
Molecular Neurodegeneration, 2023-02-21;18(1):13.
Species: Primate
Sample Types: CSF
Applications: Western Blot -
CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity
Authors: P Filppu, JT Ramanathan, KJ Granberg, E Gucciardo, H Haapasalo, K Lehti, M Nykter, V Le Joncour, P Laakkonen
JCI Insight, 2021-05-10;6(9):.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Co-Immunoprecipitation, PLA, Western Blot -
Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.
Authors: Anderson J, Titz B, Akiyama R, Komisopoulou E, Park A, Tap W, Graeber T, Denny C
Mol Cancer Res, 2014-08-04;12(12):1740-54.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Neutralization -
NF-kappaB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma.
Authors: McFarland B, Hong S, Rajbhandari R, Twitty G, Gray G, Yu H, Benveniste E, Nozell S
PLoS ONE, 2013-11-11;8(11):e78728.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Authors: Zhang Z, Lee JC
Nat. Genet., 2012-07-01;44(8):852-860.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Disturbances in the LIF pathway in the endometrium among women with unexplained infertility.
Authors: Aghajanova L, Altmae S, Bjuresten K, Hovatta O, Landgren BM, Stavreus-Evers A
Fertil. Steril., 2008-08-05;91(6):2602-10.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
Expression of leukemia inhibitory factor and its receptors is increased during differentiation of human embryonic stem cells.
Authors: Aghajanova L, Skottman H, Stromberg AM, Inzunza J, Lahesmaa R, Hovatta O
Fertil. Steril., 2006-09-01;86(4):1193-209.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.
Authors: Queen MM, Ryan RE, Holzer RG, Keller-Peck CR, Jorcyk CL
Cancer Res., 2005-10-01;65(19):8896-904.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling.
Authors: He W, Gong K, Smith DK, Ip NY
FEBS Lett., 2005-08-15;579(20):4317-23.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Authors: Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H
Circulation, 2003-02-18;107(6):798-802.
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human gp130 Antibody
There are currently no reviews for this product. Be the first to review Human gp130 Antibody and earn rewards!
Have you used Human gp130 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image